ANTH

Anthera Pharmaceuticals, Inc. News Headlines

$2.56
*  
0.03
1.16%
Get ANTH Alerts
*Delayed - data as of Aug. 27, 2014  -  Find a broker to begin trading ANTH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ANTH After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Anthera (ANTH) Enters Oversold Territory - Tale of the Tape
8/11/2014 10:41:13 AM - Zacks.com

Anthera Pharmaceuticals (ANTH) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
8/4/2014 9:31:28 AM - Zacks.com

Anthera Acquires Sollpura from Eli Lilly - Analyst Blog
7/18/2014 5:20:00 PM - Zacks.com

Sector Update: Health Care Stocks Swept Up in Biotech Sell-Off as Fed Sees Values 'Stretched'
7/15/2014 1:25:04 PM - MT Newswires

Sector Update: Health Care
7/15/2014 1:08:41 PM - MT Newswires

Exelixis (EXEL) Soars: Stock Adds 23% in Session - Tale of the Tape
7/15/2014 9:04:00 AM - Zacks.com

ANTH Rekindles Hope For Sollpura, AERI Launches Rockets, Pay Attention To ADHD
7/15/2014 1:24:00 AM - RTT News

Anthera Acquires Sollpura From Lilly
7/14/2014 4:54:00 PM - RTT News

Fire Up The Immuno-Oncology Powerhouses: John McCamant
6/19/2014 5:39:00 PM - Seeking Alpha

Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape
5/16/2014 8:51:00 AM - Zacks.com

Anthera Pharmaceuticals: Recent Developments, Both Good And Bad
10/31/2013 1:20:00 PM - Seeking Alpha

A Promising Future For Anthera's Blisibimod
9/27/2013 5:58:00 PM - Seeking Alpha

BioLineRx Files for BL-7010 Study Initiation - Analyst Blog
9/25/2013 5:25:01 PM - Zacks.com

Biogen Upped to Outperform - Analyst Blog
9/19/2013 11:30:01 AM - Zacks.com

Data Published on Alnylam's ATTR Candidates - Analyst Blog
8/29/2013 4:34:43 PM - Zacks.com

Voluntary Recall at Alexion - Analyst Blog
8/21/2013 11:25:24 AM - Zacks.com

MannKind to Raise $40M from Deerfield - Analyst Blog
8/19/2013 10:25:30 AM - Zacks.com

ANTH's Blisibimod Enters Phase III - Analyst Blog
4/1/2013 7:11:38 PM - Zacks.com

Anthera Shifts Its Strategy For Blisibimod
1/23/2013 11:56:00 AM - Seeking Alpha

Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside
11/29/2012 8:11:00 AM - Seeking Alpha

Anthera Recovering After Long Fall
11/27/2012 10:39:00 AM - Seeking Alpha

Anthera's Lupus Drug Gets Second Chance After Clinical Trial Disaster
11/14/2012 11:28:00 AM - Seeking Alpha

GlaxoSmithKline: Buy For 4.5% Yield
10/8/2012 10:03:00 AM - Seeking Alpha

Pick Biotech Winners Like A Pro: John McCamant
10/5/2012 1:03:00 PM - Seeking Alpha

Pre-Market Most Active for Mar 12, 2012 : BAC, ING, ZOLL, YOKU, RIO, SIRI, QQQ, UN, OREX, ANTH, ABB, AAPL
3/12/2012 8:39:55 AM - NASDAQ.com News